Victoria Avenue Family Practice

29/05/2026

15/05/2026

Respiratory syncytial virus (RSV) vaccine for older Australians – consumer fact sheet

15/05/2026

Respiratory syncytial virus (RSV) maternal vaccination consumer fact sheet

24/04/2026

From 15 May 2026, Arexvy, a respiratory Syncytial Virus (RSV) vaccine will be funded through the National Immunisation Program for Aboriginal and Torres Strait Islander people aged 60 years and over and adults aged 75 years and over.

Who is recommended an RSV vaccine:

Women at 28 to 36 weeks pregnancy are recommended to receive the maternal RSV vaccine (Abrysvo®) to protect their baby against serious illness from RSV. The vaccine is available to eligible
women for free through the National Immunisation
Program (NIP).

All adults aged 60 and over including Aboriginal and Torres Strait Islander people and people aged 50 to 59 with medical risk conditions are recommended to receive Abrysvo® or Arexvy® RSV
vaccines. RSV vaccines for these groups are not funded through the NIP. They can be purchased privately through general practices or pharmacies, but the cost cannot be claimed or reimbursed
through the NIP or state or territory programs.

Arexvy is effecive at preventing severe lower respiratory tract infection in adults aged 60 and over.

Please call us for more information and to make an appointment for this vaccine.